Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-Rivasterat
Rivasterat

Chemical Structure : Rivasterat

CAS No.: 2446590-96-9

Rivasterat (CU06-1004, Sac-1004)

Catalog No.: PC-25025Not For Human Use, Lab Use Only.

Rivasterat (CU06-1004, Sac-1004) is a small molecule vascular leakage blocker and endothelial dysfunction blocker, inhibits endothelial hyperpermeability induced by VEGF, histamine and thrombin via stabilization of cortical actin ring and AJ proteins at the cell-cell junction.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

Rivasterat (CU06-1004, Sac-1004) is a small molecule vascular leakage blocker and endothelial dysfunction blocker, inhibits endothelial hyperpermeability induced by VEGF, histamine and thrombin via stabilization of cortical actin ring and AJ proteins at the cell-cell junction.
Treatment of Rivasterat (CU06-1004, Sac-1004) in ECs increased cAMP levels and activated Rac, both of which are known to strengthen endothelial barrier.
Rivasterat (CU06-1004, Sac-1004) blocks vascular leakage by enhancing endothelial integrity via the cAMP/Rac/cortactin pathway.
Rivasterat (CU06-1004, Sac-1004) reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation
Rivasterat (CU06-1004, Sac-1004) inhibited angiogenesis and confirmed vascular stabilization in the oxygen-induced retinopathy model.

Physicochemical Properties

M.Wt 626.83
Formula C37H54O8
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

methyl (E)-6-((3S,8S,9S,10R,13S,14S,17R)-3-(((2S,5S,6R)-5-acetoxy-6-(acetoxymethyl)-5,6-dihydro-2H-pyran-2-yl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)hept-5-enoate

References

1. Zhang H, et al. Exp Mol Med. 2022 Jan;54(1):23-34.

2. Noh M, et al. Eur J Pharmacol. 2023 Jan 15;939:175427.

3. Agrawal V, et al. Oncotarget. 2014 May 15;5(9):2761-77.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: